---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-024000"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T01:08:03.588531+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kintara Q1 net loss $4.6M; pauses REM-001 to save $3M, continues VAL-083 trial

## Summary
- Net loss of $4.6M ($0.07/share) for quarter ended Sep 30, 2022, vs $6.0M ($0.25) a year ago.
- Cash and equivalents $7.1M at Sep 30, down from $11.8M at Jun 30; net $1.9M from Lincoln Park equity line.
- Paused REM-001 CMBC program to conserve cash; expects to save ~$3.0M through 2023.
- VAL-083 GBM AGILE registrational study ongoing; top-line data expected around end of 2023.
- Entered $20M purchase agreement with Lincoln Park Capital; $1.9M received as of Nov 8.

## SEC filing metadata
- accession: 0000950170-22-024000
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024000/0000950170-22-024000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024000/ktra-20221109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-024000
- JSON: https://secwatch.observer/filing/0000950170-22-024000.json
- Plain text: https://secwatch.observer/filing/0000950170-22-024000.txt

## Key facts
- Earnings Releases
  TuHURA Biosciences, Inc./NV reported the three months ended September 30, 2022 results: net income net loss of approximately $4.6 million, or $0.07 per share, EPS $0.07 per share.
  - Period: the three months ended September 30, 2022
  - Net income: net loss of approximately $4.6 million, or $0.07 per share
  - EPS: $0.07 per share
  - Result: reported results
  source text: For the three months ended September 30, 2022, Kintara reported a net loss of approximately $4.6 million, or $0.07 per share, compared to a net loss of approximately $6.0 million, or $0.25 per share, for the three months ended September 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024000/0000950170-22-024000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.